WithdrawnPhase 1ketamine
The Dreamy Jet Study
Sponsored by University of Wisconsin, Madison
NCT ID
NCT06919198
Start Date
2025-09
Est. Completion
2028-08
About This Study
The goal of this clinical trial is to see if a device known as a jet-injection system can help deliver a single dose of a sedating medication with less pain and stress than current methods. Participants will receive a dose of the sedative in their arm or thigh before their procedure at the sedation clinic.
Conditions Studied
Interventions
- •Ketamine
Eligibility
Age:2 Years - 15 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Referred to UW Health American Family Children's Hospital Pediatric Sedation Clinic for minimally invasive procedures such as blood draw, IV placement, or immunization * Age 2-15 years * Weight \<40kg Exclusion Criteria: * Participants with elevated intracranial pressure * Participants with uncontrolled hypertension * Participants who are pregnant or possibly pregnant (i.e., people of child bearing potential unable to provide a negative pregnancy test) * Participants who received a dose of medication within 2 hours of their appointment with the intention of sedation (i.e., benzodiazepines, opioids, alpha-2 agonists, 1st generation antihistamines) * Participants who are receiving medications which might enhance the sympathomimetic effect of ketamine (i.e., theophylline, aminophylline, amphetamine, or pseudoephedrine) * Participants who are receiving medications that might interfere with the expected pharmacokinetics of ketamine (i.e., ketoconazole, clarithromycin, rifampin, or carbamazepine) * Participant's parent/legal guardian requires a translator for communication about the patient's medical care
Study Locations (1)
University of Wisconsin - Madison
Madison, Wisconsin, United States